NEW YORK, April 01, 2019 (GLOBE NEWSWIRE) -- Mustang Bio, Inc. (“Mustang”) (NASDAQ: MBIO), a clinical-stage biopharmaceutical company focused on translating today’s medical breakthroughs in cell and gene therapies into potential cures for hematologic cancers, solid tumors and rare genetic diseases,...
FARMINGTON, Conn. , March 22, 2019 /PRNewswire/ -- Horizon Technology Finance Corporation (Nasdaq: HRZN) (the "Company" or "Horizon") today announced that it has priced an underwritten public offering of 2,000,000 shares of its common stock at a price to the public of $12.14 per share for total...
FARMINGTON, Conn. , March 21, 2019 /PRNewswire/ -- Horizon Technology Finance Corporation (Nasdaq: HRZN) (the "Company" or "Horizon") announced today a proposed underwritten primary offering of 2,000,000 shares of its common stock. In connection with the proposed offering, the Company intends to...
FARMINGTON, Conn. , March 5, 2019 /PRNewswire/ -- Horizon Technology Finance Corporation (NASDAQ: HRZN) ("Horizon") (the "Company"), a leading specialty finance company that provides capital in the form of secured loans to venture capital backed companies in the technology, life science,...
- Net Investment Income per Share of $0.34 - - NII Covers Distributions for Year - - Third Consecutive Quarter of Portfolio Growth - FARMINGTON, Conn. , March 5, 2019 /PRNewswire/ -- Horizon Technology Finance Corporation (NASDAQ: HRZN) ("Horizon" or the "Company"), a leading specialty finance...
FARMINGTON, Conn. , Feb. 19, 2019 /PRNewswire/ -- Horizon Technology Finance Corporation (NASDAQ: HRZN) ("Horizon") (the "Company"), a leading specialty finance company that provides capital in the form of secured loans to venture capital backed companies in the technology, life science, healthcare...
FARMINGTON, Conn. , Oct. 30, 2018 /PRNewswire/ -- Horizon Technology Finance Corporation (NASDAQ: HRZN) ("Horizon"), a leading specialty finance company that provides capital in the form of secured loans to venture capital backed companies in the technology, life science, healthcare information and...
Grows Net Investment Income to $0.30 per share; NAV Increases to $11.66 per share; Portfolio Increases for Second Consecutive Quarter FARMINGTON, Conn. , Oct. 30, 2018 /PRNewswire/ -- Horizon Technology Finance Corporation (NASDAQ: HRZN) (the "Company" or "Horizon"), a leading specialty finance...
FARMINGTON, Conn. , Oct. 16, 2018 /PRNewswire/ -- Horizon Technology Finance Corporation (NASDAQ: HRZN) ("Horizon") ("Company"), a leading specialty finance company that provides capital in the form of secured loans to venture capital backed companies in the technology, life science, healthcare...
